In another study, the median levels of aCL IgG/IgM and aβ2GPI IgG/IgM in COVID-19 patients were lower than in APS (15/4 GPL/MPL unit versus 65/6.2 GPL/MPL unit) (41). The gene discussed is ACLY; the disease is COVID-19.